跳至主要内容
临床试验/DRKS00031070
DRKS00031070
招募中
3 期

Determination of central pain modulation biomarkers to characterize and profile cancer patients with refractory pain and adaptation and validation of a home-based transcranial brain stimulation procedure for their palliative care - PAINLESS-TreatCANCERPAI

niversitätsmedizin Göttingen0 个研究点目标入组 450 人2023年1月31日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
C00-C97
发起方
niversitätsmedizin Göttingen
入组人数
450
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年1月31日
结束日期
待定
最后更新
去年
研究类型
Interventional
性别
All

研究者

发起方
niversitätsmedizin Göttingen

入排标准

入选标准

  • Adult subjects \= 18 years old.
  • \-Able to provide informed consent to participate in the study.
  • \-Able to self\-report pain.
  • \-To have a diagnosis of cancer affecting lung, breast, pancreas or colon (with metastases or not).
  • \-The life expectancy of at least six months.
  • \-Cancer pain persisting despite best tolerated pharmacological treatment
  • \-Pain rated \>\= 5 on a 0\-10 Numeric Rating Scale (NRS) persisting for over 1 month prior to enrolment.
  • \-Ability to use internet and WhatsApp or have a person (relative, caregiver) to help them.

排除标准

  • \-Pregnant women or women of fertile age that did not have efficacious contraception during the whole period of the study.
  • \-Neurological or psychiatric diseases (except anxiety or depression)
  • \-Unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure or chronic obstructive pulmonary disease).
  • \-History of neurosurgery, traumatic brain injury with loss of consciousness, and/or cortical lesions
  • \-Present risk factors for receiving tES (e.g., history of epilepsy, metal devices in the brain, etc.).
  • \-History of non\-malignant chronic pain.

结局指标

主要结局

未指定

相似试验